Kraig Biocraft Laboratories (Kraig Biocraft Laboratories) Other Current Assets

: $0.01 Mil (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

Kraig Biocraft Laboratories's other current assets for the quarter that ended in Dec. 2023 was $0.01 Mil.

Kraig Biocraft Laboratories's quarterly other current assets declined from Jun. 2023 ($0.10 Mil) to Sep. 2023 ($0.10 Mil) and declined from Sep. 2023 ($0.10 Mil) to Dec. 2023 ($0.01Mil).

Kraig Biocraft Laboratories's annual other current assets increased from Dec. 2021 ($0.01 Mil) to Dec. 2022 ($0.11 Mil) declined from Dec. 2022 ($0.11 Mil) to Dec. 2023 ($0.01 Mil).

Kraig Biocraft Laboratories Other Current Assets Historical Data

The historical data trend for Kraig Biocraft Laboratories's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kraig Biocraft Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Assets

0.03

0.01

0.11

0.01

Kraig Biocraft Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Current Assets																0.11	0.10	0.10	0.10	0.01

Kraig Biocraft Laboratories Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:

Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:

Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Kraig Biocraft Laboratories Other Current Assets Related Terms

Thank you for viewing the detailed overview of Kraig Biocraft Laboratories's Other Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Kraig Biocraft Laboratories (Kraig Biocraft Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Kraig Biocraft Laboratories Inc (OTCPK:KBLB) » Definitions » Other Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

2723 South State Street, Suite 150, Ann Arbor, MI, USA, 48104

Website

https://www.kraiglabs.com

Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fibers using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; and Dragon Silk, which combines the elasticity of Monster Silk with additional high strength elements of native spider silk; Spydasilk; and Spydra. It generates the majority of its revenues from its business across the United States.

Executives

Jonathan Richard Rice	officer: COO	2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48104
Kimberly Kraig Thompson	director, 10 percent owner, officer: CEO, CFO	2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48401